243
Participants
Start Date
August 31, 2011
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
Botulinum toxin type A
500 U, I.M. (in the muscle) injection on day 1 of a single treatment cycle.
Botulinum toxin type A
1000 U, I.M. (in the muscle) injection on day 1 of a single treatment cycle.
Placebo
I.M. (in the muscle) injection on day 1 of a single treatment cycle.
Weill Cornell Medical College, New York
Wake Forest Medical Center, Winston-Salem
Univ of North Carolina - Chapel Hill, Chapel Hill
Design Neuroscience Miami, South Miami
Parkinson's Disease & Movement Disorders Center of Boca Raton, Boca Raton
Vanderbilt University, Nashville
The Rehabilitation Institute of Chicago, Chicago
University of Texas, Dallas
Southwestern Medical Center at Dallas, Dallas
University of North Texas HSC, Fort Worth
University of Texas, Houston
University of Utah School of Medicine, Salt Lake City
Rancho Los Amigos National Rehabilitation Center, Downey
Associated Neurologist of Southern CT, PT, Fairfield
Mount Sinai School of Medicine, New York
Université catholique de Louvain av Hippocrate 10, Brussels
Clinique Universitaire, Yvoir
Neurologicka klinika, Olomouc, Olomouc
Charles University in Prague, Prague
CHU Jean MINJOZ, Besançon
CHU Brest, Brest
Centre de Réadaptation de Coubert, Coubert
Centre Hospitalier Albert Chenevier-Hopital Henri Mondor, Créteil
Hopital Raymond Poincarré, Garches
Hôpital Sébastopol, Reims
CHU Strasbourg, Strasbourg
Hopital Rangueil, Toulouse
National Institut for Medical Rehabilitation, Budapest
Petz Aladar County Hospital, Győr
University of Szeged, Szeged
Azienda Hospedaliero, Catania
Policlinico Universitario Agostino Gemelli, Roma
Malopolskie Centrum Medyczne, Krakow
Krakowska Akademia Neurologii, Warsaw
Samodzielny Publiczny Centralny Szpital Kliniczny, Warsaw
Medical Rehabilitation Center, Moscow
Scientific Center of Neurology of RAMS, Moscow
State University, Saint Petersburg
Derer's Hospital, Bratislava
Univerzitna nemocnica Bratislava, Bratislava
Lead Sponsor
Ipsen
INDUSTRY